<DOC>
	<DOC>NCT01573910</DOC>
	<brief_summary>The purpose of this study is to evaluate Moxifloxacin 0.5% relative to Ofloxacin 0.3% in the treatment of bacterial conjunctivitis in Chinese patients.</brief_summary>
	<brief_title>An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOXÂ®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Chinese. Diagnosis of bacterial conjunctivitis based on clinical observation. Understand and sign the approved informed consent. Legally authorized representative can provide informed consent for patients less than 18 years old and/or incapable of understanding the informed consent. Willing to complete all required study procedures and visits. Other protocoldefined inclusion criteria may apply. Women who are pregnant, lactating, or planning a pregnancy. Only 1 sighted eye or vision not correctable to 0.6 logMAR or better in either eye. Planned contact lens wear during the course of the study. Signs and symptoms of bacterial conjunctivitis for longer than 4 days prior to Screening (Day 1). Suspected fungal, viral, or Acanthamoeba infection. Any systemic or ocular disease or disorder, complicating factor or structural abnormality that would negatively affect the conduct or outcome of the study. History of recent surgery. Presence of concomitant systemic viral infection. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Bacterial conjunctivitis</keyword>
	<keyword>Anti-infective</keyword>
	<keyword>Antibiotics</keyword>
</DOC>